FANCD2 and chronic myelogenous leukemia, BCR-ABL1 positive: Similar to Mo7e cells, the proportion of CD34+ cells with FANCD2 foci was significantly reduced when samples were obtained from CML patients, compared to healthy CD34+ cells.